Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dieckmann Biotechnology is a leading synthetic biology company headquartered in Shenzhen, China, focused on the development and large-scale production of high-purity active ingredients. The company leverages a proprietary biocatalysis and enzyme engineering platform to create functional molecules for the pharmaceutical, nutraceutical, and personal care industries. Their product portfolio features high-value antioxidants and skin-care actives, including hydroxytyrosol, ergothioneine, and ectoine, produced through sustainable fermentation processes. Dieckmann serves as both a product developer and a CDMO partner, providing customized green chemistry solutions to global clients. By replacing traditional chemical synthesis with bio-based methods, the company aims to improve the purity and environmental footprint of essential health and beauty components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dieckmann Biotechnology.